5 Minutes with Maria Gonzalez
20 May 2016
This International Clinical Trials Day (20th May) we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future. We've sat down with MIA's Clinical Trials Manager, Maria Gonzalez to discuss.
What does a Clinical Trials Manager do and how did you get here?
In my role I work with a team of highly dedicated and caring trial co-ordinators who are responsible for looking after our trial patients. I completed a degree in nursing at The University of Sydney and worked at Royal Prince Alfred Hospital before deciding to work in clinical trials in the hope that I may contribute to life-saving research. I have been at MIA for 6 years now.
What are clinical trials so important?
Clinical trials provide patients with access to unavailable new treatments and are also the vital step in making discoveries that will enable us to find a cure for melanoma. Clinical trials are also an opportunity for patients to receive very specialised care from clinical trial co-ordinators who are available at every step along the way to support patients and their families.
What do you find most rewarding about your work?
As a nurse I am most rewarded by making a difference in the lives of those suffering with cancer. It is a privilege to be part of a patient support network at MIA and also wonderful to share in the good news when a trial treatment is successful. Although we have made significant progress and the future is positive, it is important we keep working together to find the cure.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.
Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.